APA (7th ed.) Citation

Hatanaka, T., Yata, Y., Hiraoka, A., Tada, T., Hirooka, M., Kariyama, K., . . . Nishimura, T. (2025). Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study. Liver International, 45(7), 1. https://doi.org/10.1111/liv.70192

Chicago Style (17th ed.) Citation

Hatanaka, Takeshi, et al. "Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study." Liver International 45, no. 7 (2025): 1. https://doi.org/10.1111/liv.70192.

MLA (9th ed.) Citation

Hatanaka, Takeshi, et al. "Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study." Liver International, vol. 45, no. 7, 2025, p. 1, https://doi.org/10.1111/liv.70192.